Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$9.93 - $15.39 $1,390 - $2,154
-140 Closed
0 $0
Q3 2021

Oct 12, 2021

BUY
$10.18 - $26.64 $1,221 - $3,196
120 Added 600.0%
140 $1,000
Q2 2021

Jul 19, 2021

BUY
$18.57 - $35.68 $371 - $713
20 New
20 $6,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $46.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Tsfg, LLC Portfolio

Follow Tsfg, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tsfg, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tsfg, LLC with notifications on news.